Literature DB >> 12373086

Effects of deferiprone on immune status and cytokine pattern in thalassaemia major.

Giovanni Carlo Del Vecchio1, Federico Schettini, Laura Piacente, Attilio De Santis, Paola Giordano, Domenico De Mattia.   

Abstract

OBJECTIVE: The present study was undertaken to evaluate the possible occurrence of immunological abnormalities in thalassaemia major patients treated with deferiprone (L1).
METHODS: Longitudinal observational cohort study.
RESULTS: The absolute number of CD8+ lymphocytes was high and the CD4/CD8 ratio low before L1 treatment; these parameters returned to normal after 3 months of L1 treatment. TNF-alpha, IL-2 and IL-2sRalpha were elevated before L1 treatment (11.83 +/- 1.75, 11.75 +/- 3.91, 1,409 +/- 621 pg/ml, respectively), while IL-6 was normal (2.58 +/- 0.79 pg/ml). After 12 months of treatment, IL-10 was higher than in previous periods, although always within the normal range. TNF-alpha, IL-2 and IL-2sRalpha returned to normal after 12, 6, and 3 months of L1 treatment, respectively. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373086     DOI: 10.1159/000064705

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  15 in total

1.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

2.  Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.

Authors:  Matthew E Sweeney; Joyce G Slusser; Sharon G Lynch; Stephen H Benedict; Sharon L Garcia; Laura Rues; Steven M LeVine
Journal:  Int Immunopharmacol       Date:  2011-07-30       Impact factor: 4.932

3.  Genetic support of a causal relationship between iron status and atrial fibrillation: a Mendelian randomization study.

Authors:  Tianyi Wang; Jun Cheng; Yanggan Wang
Journal:  Genes Nutr       Date:  2022-05-30       Impact factor: 4.423

4.  Increased leucocyte apoptosis in transfused β-thalassaemia patients.

Authors:  Patrick B Walter; John Porter; Patricia Evans; Janet L Kwiatkowski; Ellis J Neufeld; Thomas Coates; Patricia J Giardina; Robert W Grady; Elliott Vichinsky; Nancy Olivieri; Felicia Trachtenberg; Daniele Alberti; Ellen Fung; Bruce Ames; Annie Higa; Paul Harmatz
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

Review 5.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Comparison of vascular complications between conventional treatment and bone marrow transplantation for children with beta-thalassemia disease.

Authors:  Alisa Limsuwan; Darin Tubtom; Samart Pakakasama; Ampiwan Chaunsumrit
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

7.  CMV, B and C hepatitis among multi-transfused hereditary hemolytic Anemia children: an updated Egyptian experience.

Authors:  Laila M Sherief; Seham M Ragab; Mohamed A Helwa; Naglaa M Kamal; Mona R Afify; Rasha T S Mohammed; Ghada Abd Elmoniem Mokhtar; Hanan S Sherbiny
Journal:  Ital J Pediatr       Date:  2021-05-26       Impact factor: 2.638

8.  Secoisolariciresinol diglucoside abrogates oxidative stress-induced damage in cardiac iron overload condition.

Authors:  Stephanie Puukila; Sean Bryan; Anna Laakso; Jessica Abdel-Malak; Carli Gurney; Adrian Agostino; Adriane Belló-Klein; Kailash Prasad; Neelam Khaper
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia.

Authors:  Tubagus Djumhana Atmakusuma; Ralph Girson; Sukamto Koesnoe
Journal:  Anemia       Date:  2021-06-17

Review 10.  Ineffective erythropoiesis in β -thalassemia.

Authors:  Jean-Antoine Ribeil; Jean-Benoit Arlet; Michael Dussiot; Ivan Cruz Moura; Geneviève Courtois; Olivier Hermine
Journal:  ScientificWorldJournal       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.